Lowest liabilities-to-equity
Companies ranked mechanically by latest liabilities / equity ratio from SEC companyfacts, sorted from lower reported ratios upward.
Descriptive ranking — not investment advice. Mechanical ranking by stated metric from SEC/FRED data; not a recommendation, endorsement, or investment judgment. As of: 2026-07-29. See Disclaimer.
Chart
Table
| Rank | Company | Liabilities / equity | FY | Period end | Comparability | Regime | Extra |
|---|---|---|---|---|---|---|---|
| 1 | LTBR - LIGHTBRIDGE Corp | 0.00 | 2025 | as of 2025-12-31 | 0d | operating | |
| 2 | QUBT - Quantum Computing Inc. | 0.01 | 2025 | as of 2025-12-31 | 0d | operating | |
| 3 | PPTA - PERPETUA RESOURCES CORP. | 0.02 | 2025 | as of 2025-12-31 | 0d | operating | |
| 4 | MNPR - Monopar Therapeutics | 0.02 | 2025 | as of 2025-12-31 | 0d | operating | |
| 5 | MLYS - Mineralys Therapeutics, Inc. | 0.02 | 2025 | as of 2025-12-31 | 0d | operating | |
| 6 | BNTC - Benitec Biopharma Inc. | 0.02 | 2025 | as of 2025-06-30 | about 6 months before row reference (-184d) | operating | |
| 7 | ASST - Strive, Inc. | 0.02 | 2025 | as of 2025-12-31 | 0d | financial | |
| 8 | NNE - Nano Nuclear Energy Inc. | 0.03 | 2025 | as of 2025-09-30 | about 3 months before row reference (-92d) | operating | |
| 9 | UTMD - UTAH MEDICAL PRODUCTS INC | 0.03 | 2025 | as of 2025-12-31 | 0d | operating | |
| 10 | DC - Dakota Gold Corp. | 0.03 | 2025 | as of 2025-12-31 | 0d | operating | |
| 11 | USAU - U.S. GOLD CORP. | 0.03 | 2026 | as of 2026-04-30 | about 4 months after row reference (+120d) | operating | |
| 12 | ORKA - Oruka Therapeutics, Inc. | 0.04 | 2025 | as of 2025-12-31 | 0d | operating | |
| 13 | OKLO - Oklo Inc. | 0.04 | 2025 | as of 2025-12-31 | 0d | operating | |
| 14 | ELVN - Enliven Therapeutics, Inc. | 0.04 | 2025 | as of 2025-12-31 | 0d | operating | |
| 15 | VGAS - Verde Clean Fuels, Inc. | 0.04 | 2025 | as of 2025-12-31 | 0d | operating | |
| 16 | NVEC - NVE CORP /NEW/ | 0.04 | 2026 | as of 2026-03-31 | about 3 months after row reference (+90d) | operating | |
| 17 | LBRX - LB PHARMACEUTICALS INC | 0.04 | 2025 | as of 2025-12-31 | 0d | operating | |
| 18 | TECX - Tectonic Therapeutic, Inc. | 0.04 | 2025 | as of 2025-12-31 | 0d | operating | |
| 19 | UPB - Upstream Bio, Inc. | 0.04 | 2025 | as of 2025-12-31 | 0d | operating | |
| 20 | MBX - MBX Biosciences, Inc. | 0.04 | 2025 | as of 2025-12-31 | 0d | operating | |
| 21 | MPLT - MapLight Therapeutics, Inc. | 0.05 | 2025 | as of 2025-12-31 | 0d | operating | |
| 22 | JANX - Janux Therapeutics, Inc. | 0.05 | 2025 | as of 2025-12-31 | 0d | operating | |
| 23 | AIRO - AIRO Group Holdings, Inc. | 0.05 | 2025 | as of 2025-12-31 | 0d | operating | |
| 24 | IKT - Inhibikase Therapeutics, Inc. | 0.05 | 2025 | as of 2025-12-31 | 0d | operating | |
| 25 | SERV - Serve Robotics Inc. /DE/ | 0.05 | 2025 | as of 2025-12-31 | 0d | operating | |
| 26 | FULC - Fulcrum Therapeutics, Inc. | 0.05 | 2025 | as of 2025-12-31 | 0d | operating | |
| 27 | IDR - Idaho Strategic Resources, Inc. | 0.05 | 2025 | as of 2025-12-31 | 0d | operating | |
| 28 | GENC - GENCOR INDUSTRIES INC | 0.05 | 2025 | as of 2025-09-30 | about 3 months before row reference (-92d) | operating | |
| 29 | CGON - CG Oncology, Inc. | 0.05 | 2025 | as of 2025-12-31 | 0d | operating | |
| 30 | JBIO - Jade Biosciences, Inc. | 0.05 | 2025 | as of 2025-12-31 | 0d | operating | |
| 31 | TRVI - Trevi Therapeutics, Inc. | 0.06 | 2025 | as of 2025-12-31 | 0d | operating | |
| 32 | SLP - Simulations Plus, Inc. | 0.06 | 2025 | as of 2025-08-31 | about 4 months before row reference (-122d) | operating | |
| 33 | RAPP - Rapport Therapeutics, Inc. | 0.06 | 2025 | as of 2025-12-31 | 0d | operating | |
| 34 | EWTX - Edgewise Therapeutics, Inc. | 0.06 | 2025 | as of 2025-12-31 | 0d | operating | |
| 35 | CD - Chaince Digital Holdings Inc. | 0.06 | 2025 | as of 2025-12-31 | 0d | financial | |
| 36 | HYLN - Hyliion Holdings Corp. | 0.06 | 2025 | as of 2025-12-31 | 0d | operating | |
| 37 | KULR - KULR Technology Group, Inc. | 0.06 | 2025 | as of 2025-12-31 | 0d | operating | |
| 38 | SION - Sionna Therapeutics, Inc. | 0.06 | 2025 | as of 2025-12-31 | 0d | operating | |
| 39 | ORIC - Oric Pharmaceuticals, Inc. | 0.06 | 2025 | as of 2025-12-31 | 0d | operating | |
| 40 | DSGN - Design Therapeutics, Inc. | 0.06 | 2025 | as of 2025-12-31 | 0d | operating | |
| 41 | TARA - Protara Therapeutics, Inc. | 0.07 | 2025 | as of 2025-12-31 | 0d | operating | |
| 42 | PRAX - Praxis Precision Medicines, Inc. | 0.07 | 2025 | as of 2025-12-31 | 0d | operating | |
| 43 | BCAX - Bicara Therapeutics Inc. | 0.07 | 2025 | as of 2025-12-31 | 0d | operating | |
| 44 | VCYT - VERACYTE, INC. | 0.07 | 2025 | as of 2025-12-31 | 0d | operating | |
| 45 | QBTS - D-Wave Quantum Inc. | 0.07 | 2025 | as of 2025-12-31 | 0d | operating | |
| 46 | LENZ - LENZ Therapeutics, Inc. | 0.08 | 2025 | as of 2025-12-31 | 0d | operating | |
| 47 | DNTH - Dianthus Therapeutics, Inc. /DE/ | 0.08 | 2025 | as of 2025-12-31 | 0d | operating | |
| 48 | IMNM - Immunome Inc. | 0.08 | 2025 | as of 2025-12-31 | 0d | operating | |
| 49 | USLM - UNITED STATES LIME & MINERALS INC | 0.08 | 2025 | as of 2025-12-31 | 0d | operating | |
| 50 | MPTI - M-tron Industries, Inc. | 0.08 | 2025 | as of 2025-12-31 | 0d | operating |